Health Services Stocks On The Rise With Help From 5 Stocks

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 40 points (0.3%) at 15,878 as of Tuesday, Jan. 28, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,973 issues advancing vs. 972 declining with 141 unchanged.

The Health Services industry currently sits up 0.6% versus the S&P 500, which is up 0.3%. Top gainers within the industry include Waters Corporation ( WAT), up 7.0%, PerkinElmer ( PKI), up 3.1%, Align Technology ( ALGN), up 2.7%, Grifols ( GRFS), up 2.1% and Mettler-Toledo International ( MTD), up 1.9%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $0.41 (0.5%) to $76.73 on light volume. Thus far, 246,161 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $76.53-$77.07 after having opened the day at $76.75 as compared to the previous trading day's close of $76.32.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $28.8 billion and is part of the health care sector. The company has a P/E ratio of 18.0, above the S&P 500 P/E ratio of 17.7. Shares are up 1.6% year-to-date as of the close of trading on Monday. Currently there are 13 analysts who rate Stryker Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Stryker Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Don't Get Out of Joint

Zimmer Biomet: Cramer's Top Takeaways

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal